Skip to main content
icon for Measles cases in U.S. by April 30?

Measles cases in U.S. by April 30?

icon for Measles cases in U.S. by April 30?

Measles cases in U.S. by April 30?

$479,297 Обс.

Apr 30, 2026
Polymarket

$479,297 Обс.

Polymarket

1750

$21,777 Обс.

Yes

1775

$39,332 Обс.

Yes

1800

$168,010 Обс.

No

1900

$74,279 Обс.

No

1850

$27,965 Обс.

No

2000

$57,355 Обс.

No

1950

$36,078 Обс.

No

2100

$18,603 Обс.

No

2200

$35,898 Обс.

No

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$479,297
Дата завершення
Apr 30, 2026
Ринок відкрито
Apr 16, 2026, 10:34 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Результат запропоновано: Yes

Без оскарження

Кінцевий результат: Yes

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.The Centers for Disease Control and Prevention (CDC) reports 1,792 confirmed measles cases across 37 U.S. jurisdictions as of April 23, 2026, with 93% outbreak-associated amid 22 new outbreaks this year, mainly in South Carolina, Utah, Texas, and Arizona. Nearly 92% of patients were unvaccinated or of unknown status, reflecting pockets of low MMR coverage that fuel transmission in close-knit communities. Weekly cases by rash onset have slowed markedly—to seven for the week starting April 19—continuing a downward trend from March peaks. The next CDC update, typically weekly on Thursdays, will likely incorporate late-April reports with reporting lags, determining the precise April 30 tally and market resolution.

This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No".

The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used.

Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.
Обсяг
$479,297
Дата завершення
Apr 30, 2026
Ринок відкрито
Apr 16, 2026, 10:34 AM ET
This market will resolve to "Yes" if there have been the specified amount or more confirmed cases of Measles (Rubeola) in humans in the territory of the United States of America in 2026, according to the CDC case counter by April 30, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No". The resolution source for this market will be the CDC Measles (Rubeola) counter 'Total Cases' in 2026 (see: https://www.cdc.gov/measles/data-research/index.html) at the resolution time. If the counter becomes unavailable, another credible source will be used. Note: Only cases reported by the CDC Measles (Rubeola) counter will qualify, regardless of reports from U.S. State agencies or other sources.

Результат запропоновано: Yes

Без оскарження

Кінцевий результат: Yes

Обережно з зовнішніми посиланнями.

Часті запитання

«Measles cases in U.S. by April 30?» — це ринок прогнозів на Polymarket з 9 можливими результатами, де трейдери купують і продають акції залежно від того, що, на їхню думку, станеться. Поточний лідер — «1750» з 100%, далі «1775» з 100%. Ціни відображають краудсорсингові ймовірності в реальному часі. Акції правильного результату погашаються по $1 кожна при вирішенні ринку.

Станом на сьогодні, «Measles cases in U.S. by April 30?» згенерував $479.3K загального обсягу торгів з моменту запуску ринку Mar 24, 2026. Цей рівень торгової активності відображає сильну залученість спільноти Polymarket та забезпечує, що поточні шанси базуються на глибокому пулі учасників ринку. Ви можете відстежувати рухи цін наживо та торгувати будь-яким результатом прямо на цій сторінці.

Щоб торгувати на «Measles cases in U.S. by April 30?», перегляньте 9 доступних результатів на цій сторінці. Кожен результат відображає поточну ціну — ймовірність ринку. Оберіть результат, оберіть «Так» чи «Ні», введіть суму та натисніть «Торгувати». Якщо ваш вибір правильний при вирішенні, акції «Так» виплачують $1. Якщо ні — $0. Ви також можете продати акції в будь-який час до вирішення.

Поточний фаворит для «Measles cases in U.S. by April 30?» — «1750» з 100%. Наступний — «1775» з 100%. Ці шанси оновлюються в реальному часі, коли трейдери купують і продають акції. Слідкуйте за змінами шансів з появою нової інформації.

Правила вирішення для «Measles cases in U.S. by April 30?» точно визначають, що має статися для оголошення переможця — включаючи офіційні джерела даних. Ви можете переглянути повні критерії вирішення в розділі «Правила» на цій сторінці. Рекомендуємо уважно прочитати правила перед торгівлею.